Hematologic Malignancies

• CLINICAL_TRIALS trial_result · 2025-05-22
  Clinical Trial Update: Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

  This clinical trial update notes the completed study assessing the impact of MANNA's Medically Tailored Meal Program in patients with non-te…

• CLINICAL_TRIALS research · 2025-05-20
  Clinical Trial Update: Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM) [NA]

  A feasibility study to evaluate a decentralised care pathway coordinated by an Advanced Practice Nurse for patients with solid tumors or hem…

• CLINICAL_TRIALS trial_result · 2025-05-15
  Clinical Trial Update: Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment [NA]

  Completed clinical trial evaluating a food safety educational training program designed to improve food safety knowledge and behaviors in ca…

• CLINICAL_TRIALS research · 2025-05-13
  Clinical Trial Update: Prospective Validation of the OHI Index

  A prospective trial to validate the OHI Index for HLH-related conditions, with recruitment ongoing at Meir Medical Center.

• CLINICAL_TRIALS withdrawal · 2025-05-02
  Clinical Trial Update: Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant [NA]

  This clinical trial update indicates that the study evaluating a donor stem cell boost for patients with low blood cell counts after a donor…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-04-30
  Clinical Trial Update: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer [Phase 1, Phase 2]

  Phase 1/2 clinical trial of psilocybin-assisted therapy for cancer-related anxiety in patients with metastatic cancer has completed and resu…

• CLINICAL_TRIALS research · 2025-04-27
  Clinical Trial Update: CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT [Phase 1, Phase 2]

  This is a Phase 1/2 clinical trial evaluating CD45RA-depleted donor lymphocyte infusion after TCRα/β-depleted haploidentical hematopoietic c…

• CLINICAL_TRIALS research · 2025-04-24
  Clinical Trial Update: TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT [NA]

  This clinical trial is evaluating a conditioning regimen of total body irradiation with fludarabine, busulfan, and melphalan followed by a s…

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells [NA]

  A clinical trial update describing a study evaluating biomarkers' impact on the post-transplant immune response after allogeneic hematopoiet…

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)

  This clinical trial update notes that the COmPACt study, which investigates cord blood transplantation with myeloablative conditioning and p…

• CLINICAL_TRIALS withdrawal · 2025-04-08
  Clinical Trial Update: A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01) [Phase 1, Phase 2]

  A pediatric/young adult trial evaluating pembrolizumab with investigational agents for hematologic malignancies or solid tumors has been wit…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) [NA]

  This clinical trial update notes a study exploring αβ T cell and CD19+ B cell depletion for alternative donor allogeneic hematopoietic cell …

• CLINICAL_TRIALS research · 2025-03-26
  Clinical Trial Update: Early Detection and Screening of Hematological Malignancies - SANGUINE

  This clinical trial update from JaxBio Ltd discusses the SANGUINE study focused on early detection and screening for hematologic malignancie…

• CLINICAL_TRIALS research · 2025-03-20
  Clinical Trial Update: First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors [Phase 1]

  First-in-human Phase 1 trial evaluating OT-A201 in patients with selected hematologic malignancies and solid tumors; currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-03-18
  Clinical Trial Update: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. [Phase 1]

  The SG2501 safety study in subjects with relapsed or refractory hematologic malignancies and lymphoma has been terminated (Phase 1).

• CLINICAL_TRIALS trial_result · 2025-03-11
  Clinical Trial Update: Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population

  A completed clinical trial assessing usability, adherence, and diagnostic performance of PointCheck in pediatric patients with hematologic m…

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging [NA]

  A clinical trial evaluating the value of 68Ga-Pentixafor PET imaging for staging hematologic malignancies and comparing it with 18F-FDG PET/…

• CLINICAL_TRIALS research · 2025-02-27
  Clinical Trial Update: Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors [NA]

  This clinical trial update outlines the precise design of a cell therapy approach for relapsed and refractory hematologic tumors, sponsored …

• CLINICAL_TRIALS research · 2025-02-24
  Clinical Trial Update: TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies [Phase 1]

  A Phase 1 study of TGRX-1942 for advanced solid tumors and/or relapsed/refractory hematologic malignancies is currently recruiting in China.

• CLINICAL_TRIALS trial_result · 2025-02-21
  Clinical Trial Update: AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer [Phase 1, Phase 2]

  Phase 1/2 clinical trial of AZD4573 in novel combinations with anti-cancer agents for advanced hematologic malignancies; results have been p…

• CLINICAL_TRIALS research · 2025-02-20
  Clinical Trial Update: Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors [EARLY_Phase 1]

  An early-phase study evaluating JY306 universal NK cell injections for adults with relapsed or refractory CD70-positive malignant hematologi…

• CLINICAL_TRIALS research · 2025-02-19
  Clinical Trial Update: Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device [Phase 2, Phase 3]

  A Phase 2/3 clinical trial update evaluating peripheral blood stem cell transplantation with alpha beta T-cell and B-cell depletion using th…

• CLINICAL_TRIALS trial_result · 2025-02-13
  Clinical Trial Update: Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. [NA]

  The update reports on the interpretability of the Quantra Viscoelastic Test in patients with hematologic malignancies and severe thrombocyto…

• CLINICAL_TRIALS research · 2025-02-07
  Clinical Trial Update: Safety and Feasibility of a Multidisciplinary Programme of Integrated Hospital-home Management With Early Discharge of Patients With Haematological Malignancies Undergoing High-dose Chemotherapy in Hospital [NA]

  This clinical trial update outlines a multidisciplinary program for integrated hospital-home management with early discharge for patients wi…

• CLINICAL_TRIALS trial_result · 2025-01-24
  Clinical Trial Update: PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]

  Phase 2 trial evaluating palmitoylethanolamide (PEA) for relief of chemotherapy-induced peripheral neuropathy; study is active-not-recruitin…